Hi-Q Marine Biotech International Ltd. for the evaluation of cutaneous tolerance of Ocean Re-New® Intensive Day cream by primary irritant patch test has been conducted after the approval based on standard operating procedures of Ellead IRB following Ministry of Food and Drug Safety (MFDS) regulations for approval regarding the functional cosmetics (2021-55)1, Personal Care Products Council (PCPC) Safety Evaluation Guidelines2 and Draize Dermal Irritation Scoring System3 with clinical reading according to the EPA (Environmental Protection Agency) Standard Evaluation Procedure Dermal Classification System4 as the standard.
Ocean Re-New® Intensive Day cream
by primary irritantpatch test Results
1. Volunteers: 34 (final 31 females and 2 males, average age 46.48 ± 7.28 years old)
2. Results:The results demonstrated that Ocean Re-New® Intensive Day cream (#1) has the grade of “Negligible”.
Also the test product did not cause any special adverse skin reactions during the test period other than those foreseeable or concomitant positive reactions of patch tests.
*All testers have passed the sensitivity and skin irritation test, but it does not mean that all people will not have skin sensitivity or irritation.
Research organization:Ellead Co., Ltd.
The first professional institution for human clinical trials of cosmetics in South Korea
Registered Institutional Review Board (IRB) in South Korea and the United States
Developed multiple patented efficacy testing technologies
Assisted the MFDS in South Korea in establishing various cosmetic efficacy evaluation guidelines
Owns a database of approximately 50,000 Asian skin test subjects
Representative director:
Kyung Soo Byun President
Research director:
Tae Kee Moon, M.D. Dermatologist
◤Product Details https://en.hiq-beauty.com/白絲絨經典乳霜